1. Academic Validation
  2. TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner

TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner

  • PLoS Pathog. 2020 Apr 13;16(4):e1008507. doi: 10.1371/journal.ppat.1008507.
Molly Ohainle 1 Kyusik Kim 2 Sevnur Komurlu Keceli 3 Abby Felton 1 Ed Campbell 3 Jeremy Luban 2 Michael Emerman 1
Affiliations

Affiliations

  • 1 Divisions of Human Biology and Basic Sciences, Fred Hutch, Seattle, Washington, United States of America.
  • 2 Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • 3 Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University, Chicago, Maywood, Illinois, United States of America.
Abstract

The HIV-1 capsid protein makes up the core of the virion and plays a critical role in early steps of HIV replication. Due to its exposure in the cytoplasm after entry, HIV capsid is a target for host cell factors that act directly to block Infection such as TRIM5α and MxB. Several host proteins also play a role in facilitating Infection, including in the protection of HIV-1 capsid from recognition by host cell restriction factors. Through an unbiased screening approach, called HIV-CRISPR, we show that the CPSF6-binding deficient, N74D HIV-1 capsid mutant is sensitive to restriction mediated by human TRIM34, a close paralog of the well-characterized HIV restriction factor TRIM5α. This restriction occurs at the step of reverse transcription, is independent of interferon stimulation, and limits HIV-1 Infection in key target cells of HIV Infection including CD4+ T cells and monocyte-derived dendritic cells. TRIM34 can also restrict some SIV capsids. TRIM34 restriction requires TRIM5α as knockout or knockdown of TRIM5α results in a loss of Antiviral activity. Through immunofluorescence studies, we show that TRIM34 and TRIM5α colocalize to cytoplasmic bodies and are more frequently observed to be associated with infecting N74D capsids than with WT HIV-1 capsids. Our results identify TRIM34 as an HIV-1 CA-targeting restriction factor and highlight the potential role for heteromultimeric TRIM interactions in contributing to restriction of HIV-1 Infection in human cells.

Figures